Fiera Capital Corp trimmed its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.9% during the third quarter, according to the company in its most recent filing with the Securities and ...

This compares with $11.49 billion for the same period the year before. As of Friday's close, AstraZeneca's stock was down 6.6% since the start of 2024 and about 1.85% over the last 12 months. WHAT TO ...

Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a £110 ($143.19) price objective on shares of ...

The OBR (Office for Budget Responsibility) anticipates economic output in Britain to expand by 1.8% in 2026 and by 1.5% in ...

The AstraZeneca (LSE:AZN) share price just dipped below £100 per share. The stock has seriously underperformed in recent months, falling from above £130 in August. So, let’s take a look at what’s ...

Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

While AstraZeneca and Novo Nordisk are developing similar candidates ... or issue a lot of new shares to get its therapies out the door. Therefore, buying its stock won't leave you at as high of a ...

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...

Miller Value Partners portfolio manager John Spallanzani joined ‘Mornings with Maria’ to discuss the U.S. economy and stock market as oil prices fall to $78 a barrel. Sen. Shelley Moore Capito, R-W.